Pirfenidone Tablet, Coated
Product Images NDC 46708-479

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 46708-479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pirfenidone Figure1)

A cumulative distribution plot comparing percentage of patients by absolute change in %FVC from baseline to week 52 for Pirfenidone (n=278) and placebo (n=277). The x-axis shows absolute change in %FVC with negative values indicating worsening and positive values indicating no decline or improvement. The y-axis shows percentage of patients. Two distinct curves are shown: a solid line for Pirfenidone and a dotted line for placebo, highlighting different patient response distributions.*

FDA Label Image

Figure 2 (Pirfenidone Figure2)

Line graph showing mean change in Forced Vital Capacity (FVC) in milliliters over 52 weeks comparing Pirfenidone (n=278) and Placebo (n=277). The graph shows greater decline in FVC for Placebo group compared to Pirfenidone, with time points at 0, 13, 26, 39, and 52 weeks on the x-axis and mean change in FVC on the y-axis.*

FDA Label Image

Figure 3 (Pirfenidone Figure3)

Kaplan-Meier survival curve chart showing the percentage of patients alive over time in weeks for Pirfenidone versus placebo. The solid line represents Pirfenidone (n=623) and the dotted line represents placebo (n=624). The chart includes a hazard ratio (HR) with a 95% confidence interval (CI) and a table of patients at risk at various time points.*

FDA Label Image

500 Tablets (Pirfenidone mg 267)

Label for Pirfenidone Tablets 267 mg, a coated oral tablet manufactured by Alembic Pharmaceuticals Limited. The label states the product contains 267 mg of pirfenidone per film-coated tablet, includes storage instructions, package size of 500 tablets, and a barcode.*

FDA Label Image

500 Tablets (Pirfenidone mg 801)

Pirfenidone Tablets 801 mg coated tablets packaging label from Alembic Pharmaceuticals Limited. The label indicates each tablet contains 801 mg of pirfenidone and includes a 500-tablet count. Additional information includes storage instructions and a barcode.*

FDA Label Image

Pirfenidone (Pirfenidone Structure)

Chemical structure of pirfenidone, showing a fused benzene ring and pyridone ring with a methyl group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.